He adds that the actual revenue from orphan drugs can vary greatly: “If the therapy being developed is considered to be transformative (for example, a gene therapy that has the potential to cure ...

Research on NICE and orphan drugs Rare diseases are a focus for many – for example, the ABPI’s chief executive, Richard Torbett, focused on rare diseases in a #MyYearInMedicine highlight - and ...

But orphan wells are a problem, too, not just an opportunity. “It’s basically a Herculean task that they’re biting off a bit ...

The “Printout Posse” is all together now, but if this latest episode of Orphan Black: Echoes proves anything, it’s that together … Once again, the writers have stepped up to bat and ...

The story of Orphan Black: Echoes took a very different approach to its plot than Orphan Black’s. In the first season of the original series, the focus was on figuring out why there were clones ...

“Orphan Black: Echoes” has been canceled at AMC Networks. The series aired its one and only season at the basic cabler beginning in June in the United States. The season finale, which now ...

This past Sunday brought the Season 1 finale of Orphan Black: Echoes, the buzzy new spinoff to the beloved and Emmy-winning series Orphan Black. At the time of this writing, Echoes has yet to be ...

PC Huw Orphan, 31, from Barry, Vale of Glamorgan, was convicted of grievous bodily harm following his trial at Cardiff Crown Court. Amy Burley, also an officer, suffered a broken back in the ...

In 2052, 37 years after the original series, Orphan Black: Echoes explores the scientific manipulation of human existence. It follows a group of women as they embark on a gripping journey to ...

U.S. FDA Orphan Drug exclusivity provides seven years of market exclusivity for YORVIPATH in the United States for the treatment of ...

Agios Pharmaceuticals has announced that the US FDA has granted orphan drug designation to tebapivat to treat myelodysplastic syndromes.

Mitapivat, the company’s lead PK activator, was previously granted FDA orphan drug designation for the treatment of PK deficiency, thalassemia, and sickle cell disease. Tebapivat is not approved for ...